Huichung T. Ling

Hematology Oncology | Hematology | Oncology
39400 Paseo Padre Parkway
Third Floor - Suite 307
Fremont, CA 94538

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer.

Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer.

Journal: Gynecologic oncology
Published: October 04, 2016
Showing 1-1 of 1

Last Updated: 09/26/2026